STATE STREET CORP - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 75 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 5.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2022$68,000
-8.1%
172,640
+32.4%
0.00%
Q2 2022$74,000
-38.8%
130,440
+21.0%
0.00%
Q1 2022$121,000
-19.3%
107,840
+5.0%
0.00%
Q4 2021$150,000
-51.3%
102,7400.0%0.00%
Q3 2021$308,000
-35.4%
102,7400.0%0.00%
Q2 2021$477,000
-86.7%
102,740
-82.8%
0.00%
Q1 2021$3,577,000
+9.2%
596,179
-4.6%
0.00%
Q4 2020$3,276,000
+60.4%
625,176
+5.9%
0.00%
Q3 2020$2,043,000
-59.1%
590,596
+2.5%
0.00%
Q2 2020$5,001,000
+85.6%
576,128
+24.0%
0.00%
Q1 2020$2,694,000
-23.5%
464,541
-4.9%
0.00%
Q4 2019$3,521,000
+35.9%
488,317
+15.0%
0.00%
Q3 2019$2,591,000
-37.1%
424,748
-2.0%
0.00%
Q2 2019$4,117,000
+21.4%
433,390
+3.7%
0.00%
Q1 2019$3,391,000
-48.1%
418,066
+4.1%
0.00%
-100.0%
Q4 2018$6,531,000
+366.5%
401,649
+367.5%
0.00%
Q3 2018$1,400,000
+131.8%
85,922
+114.3%
0.00%
Q2 2018$604,00040,1000.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Mayo Clinic 1,571,981$7,294,0008.07%
Invus Financial Advisors, LLC 1,094,998$5,081,0001.01%
Founders Fund V Management, LLC 491,751$2,282,0000.78%
Tibra Equities Europe Ltd 80,700$374,0000.12%
GSA CAPITAL PARTNERS LLP 205,882$955,0000.11%
Hall Private Wealth Advisors 18,500$86,0000.06%
20/20 Capital Management, Inc. 42,840$199,0000.05%
OCCUDO QUANTITATIVE STRATEGIES LP 64,789$301,0000.05%
JACOBS LEVY EQUITY MANAGEMENT, INC 759,918$3,526,0000.02%
PDT Partners, LLC 74,178$344,0000.02%
View complete list of UNITY BIOTECHNOLOGY INC shareholders